abstract |
Disclosed are 2,4-diaryl substituted pyrimidine diamines with a sulphonamide substituted phenyl ring of formula (III), wherein the substituents are as defined in the specification. Also disclosed is their use in treating conditions in which modulation of the JAK pathway or inhibition of the JAK kinases, particularly JAK3, may be useful. |